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Morphology of ischemic acute renal failure, normal function, and
cyclosporine toxicity in cyclosporine-treated renal allogran recipients. To
characterize morphologic changes in the early post-transplant period in
cyclosporine-treated renal allograft recipients, we examined biopsies
from three groups of cyclosporine-treated patients: normal function (N
= 9), ischemic acute renal failure or •'acute tubular necrosis" (N = 12),
and cyclosporine toxicity (N = 7). Groups were compared with each
other and with previously studied groups of azathioprine-treated pa-
tients and native kidney patients. The interstitial infiltrate commonly
observed in normally functioning azathioprine-treated grafts was not
observed in normally functioning cyclosporine-treated grafts, but two
of nine such grafts had a significant venulitis, a change also seen in three
of the patients with cyclosporine nephrotoxicity. "Acute tubular necro-
sis" (ATN) in cyclosponne-treated graft recipients was characterized
by focal necrosis of complete tubular cross sections, a finding normally
rare in other types of ATN, and by shedding into the tubular lumen of
tubular cells with non-pyknotic nuclei, a finding supporting our previ-
ous observation of detachment of viable tubular cells in ATN but not in
the normal kidney. Hyaline arteriolar thickening was the only morpho-
logic finding on biopsy which distinguished patients with cyclosporine
nephrotoxicity from other groups. In summary, the morphologic
changes observed in cyclosporine-treated renal allograft recipients with
ATN or normal function are quite different from those observed in
azathioprine-treated patients. Cyclosporine appears to enhance the
tubular injury observed in ATN. Hyaline arteriolar thickening is the
main distinguishing feature of cyclosporine nephrotoxicity.
The clinical status of the average renal transplant patient has
always been more complicated than that of the average patient
with native kidney disease. The use of cyclosporine and other
newer immunosuppressive agents, while greatly increasing suc-
cess rates for transplantation, has increased the complexity of
problems encountered in allograft recipients by another order of
magnitude. Entities rare or unheard of in previous eras, such as
cyclosporine nephrotoxicity [1—4], post-transplant lymphopro-
liferative disease [5, 6], and systemic capillary leak due to
cytokine release [7, 8], must now be considered. Unequivocal
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"pure" cases of single-disease entities are becoming rare, and
transplant renal biopsies are being employed more frequently in
an effort to sort out complicated clinical circumstances. An
international effort to standardize interpretation and classifica-
tion of such biopsies has recently been initiated [9, 10]. Animal
models have assumed an increasingly important role in allowing
the study of pure disease states, thus enhancing the understand-
ing of more complex situations in human renal allografts [11,
12].
Ischemic acute renal failure, commonly referred to as "acute
tubular necrosis" (ATN), brought about by ischemia during
harvesting, preservation, or implantation, is the most common
disease process found in renal allografts in the early post-
transplant period. ATN often antedates and represents the
background for other disorders occurring in transplanted kid-
neys, and may conceal the onset of rejection or cyclosporine
nephrotoxicity. It is very important, therefore, that the pathol-
ogy of ATN in the renal allograft be well understood. In
addition, a better understanding of the pathophysiology of this
type of ATN would aid in the development of strategies to
prevent this complication of transplantation. Determining
which renal morphologic changes are uniformly present during
clinical ATN and absent in the well functioning graft can
provide a clue to the pathophysiology of ATN by suggesting
direct linkage between morphologic changes and renal func-
tional impairment [13, 14].
In a previous study, carried out in patients with steroid-
azathioprine immunosuppression, we have shown significant
morphologic differences between ATN occurring in the trans-
planted kidney and in the native kidney [13]. It is likely that the
morphology of ATN in the renal allograft is qualitatively and
quantitatively different in patients immunosuppressed with cy-
closporine, an agent that may increase the incidence of initial
transplant non-function. In the present study of renal biopsies
from cyclosporine-treated transplant patients, we have com-
pared the morphologic changes observed in transplant ATN or
cyclosporine nephrotoxicity to those observed in normally-
functioning allografts using light and electron microscopy. We
have contrasted pathologic alterations found in this study with
those in our previous studies of native kidney ATN [14] and
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Table 1. Clinical status and renal function at time of allograft biopsy
Post-transplant
EM# day of biopsy Creatinine Clinical status
VC 2328 17 145 Ni function
VC 2440 20 103 Nl function
VC 2714 15 150 NI function
VC 2283 15 94 Nl function
VC 22% 22 143 N! function
VC 2751 26 130 Ni function
VC 2780 14 100 Ni function
VC 2877 37 120 Ni function
YC 0579 8 150 Ni function
VC 0564 9 477 ATN
VC 0565 35 186 ATN
VC 0566 8 177 ATN
VC 0567 7 1043 ATN
VC 2057 6 462 ATN
YB 9511 9 1379 ATN
VB 9883 10 336 ATN
VB 9890 23 609 ATN + CsA tox.
VC 2056 7 980 ATN + CsA tox.
VC 0569 27 769 ATN + CsA tox.
VC 0574 9 1326 ATN + CsA tox.
VC 0575 23 840 ATN + CsA tox.
VB 9893 20 220 CsA tox.
VC 2055 5 462 CsA tox.
VC 0585 15 504 CsA tox.
VC 2058 15 255 CsA tox.
VC2059 17 187 CsAtox.
VC 2060 61 238 CsA tox.
VB 9513 21 407 CsA tox.
ATN in renal allograft patients on steroid-azathioprine immu-
nosuppression [13]. We have also studied the changes observed
during normal function and during episodes of cyclosporine
nephrotoxicity.
Methods
To optimize our ability to obtain biopsies that represented
pure clinical states, renal biopsy specimens from four different
institutions—Johns Hopkins Hospital (Baltimore, Maryland,
USA), the University of Western Ontario (London, Ontario,
Canada), the University of Alberta (Edmonton, Alberta, Can-
ada), and the University of Aarhus (Aarhus, Denmark)—were
employed. Renal allograft biopsies were obtained between 1986
and 1990 and most were performed two to three weeks post-
transplant (range 1 to 9 weeks). The timing of the biopsies and
serum creatinine at time of biopsy for the patients in the four
groups studied are shown in Table 1. There were seven cases of
pure ATN, five cases of ATN with cyclosporine toxicity, seven
cases of pure cyclosporine toxicity, and nine cases of well
functioning renal aliografts. Biopsy timing did not differ signif-
icantly in the four groups. All patients received perioperative
cyclosporine in a dose of 8 to 10 mg/kg/day and were receiving
cyciosporine at time of biopsy in a dose necessary to achieve
therapeutic blood levels. As in our previous studies [13, 15], the
clinical assessment for group assignment was performed retro-
spectively by chart review without knowledge of pathologic
findings.
Patients with a rapid return of renal function after reduction
of cyclosporine dose were regarded as having had cyclosporine
nephrotoxicity. Patients with persisting renal failure from time
of transplantation and serum creatinine >300 mIliter four days
post-transplant were regarded as having ATN. Cases of rejec-
tion, in which renal function improved substantially after in-
creased immunosuppression, were excluded (N = 11), as were
indeterminant cases or cases in which cyclosporine therapy was
suspended (N = 13). The four centers combined performed
over 500 renal allograft biopsies a year, so it is clear the cases
employed for the present study were highly selected to repre-
sent pure states. None of the nine normal function cases had
signs of clinical rejection at the time of biopsy or previously, or
developed such signs shortly thereafter. These normal function
cases were comparable to those included in our previous
routine biopsy studies [13, 15].
Light microscopy
The portions of renal biopsy specimens for light microscopy
were fixed in 10% buffered formalin and embedded in paraffin.
Sections of 3 sm thickness were cut and stained with hematox-
ylin and eosin, PAS, silver stain, Masson trichrome stain, and
chromotope aniline blue. The biopsies were examined for the 12
light microscopic lesions of native kidney "acute tubular necro-
sis" as described by Solez, Morel-Maroger and Sraer [14], plus
additional lesions of interest in the transplanted kidney [13]. In
addition we recorded whether or not shed tubular cells present
in the tubular lumen had pyknotic nuclei. This assessment was
carried out because of our previous observation that large
numbers of live tubular cells are shed into the urine in ATN
[16]. The interstitial infiltrate was quantitated by morphometry
as described by Burdick et al [15]. These morphologic assess-
ments were carried out without knowledge of renal function or
patient group.
The light microscopic changes in the four transplant biopsy
groups were assessed as described above and compared with
the changes previously observed in native kidney ATN [14],
and in ATN in renal allografts from patients receiving steroid-
azathioprine immunosuppression [13]. These patients were
comparable to the cyclosporine-treated transplant ATN group
in both severity and duration of renal failure.
Preparation for transmission electron microscopy (TEM)
Material for electron microscopy was available from all
patients. Tissue from each end of the biopsy was fixed in 3%
glutaraldehyde, postfixed in 1% osmium tetroxide for one hour,
and dehydrated. Biopsies were embedded in Vestopal W,
Araldite, or Epon. The native kidney control biopsies and
biopsies from native ARF used for comparison were embedded
in Vestopal W or Araldite. The specimens were stained en bloc
with 2% uranyl acetate and on the grid with lead citrate.
Since the ultrastructure in different segments of the tubules
varies, it is important to identify the portion of the tubule
investigated. Using light microscopy on toluidine blue-stained
semi-thin sections, blocks were selected which contained gb-
meruli and therefore came from the cortical labyrinth. Proximal
convoluted tubules and distal tubules were studied. Blocks with
signs of mechanical damage were excluded, to avoid tissue that
had been grossly damaged by the biopsy needle or by cutting,
but no other selection criteria were used.
Electron micrographs covering each tubular cross section in
one or more pictures were studied at a final magnification of
3,525 x. Randomly selected series of micrographs covering 1/3
to 1/2 of the tubular circumference at a magnification of 11,175
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x were also studied. Only tubular cells with their nucleus
represented in the plane of section were counted.
Data from 12 native control biopsies studied in a previous
paper [17] were used for comparison along with data from 25
native kidney ATN biopsies from the same study. The native
kidney control biopsies were obtained from six patients without
signs and symptoms of renal disease and from six patients with
minimal change nephropathy or mild glomerulonephritis.
The 25 biopsies from patients with native ATN used for
comparison of ultrastructure were obtained during isehemic or
hypotensive ARF or in the early recovery phase. The detailed
clinical and laboratory data for these patients have been re-
ported earlier [18]. Eleven biopsies from 10 patients were
obtained in the active phase of ARF, defined as the period when
creatinine clearance was 5 mllmin or lower. The age of these
patients was 24 years to 71 years, six were males and five
females. The biopsies were obtained at days 2 to 25 after onset
of ARF. Fourteen biopsies from 14 patients (age range, 17 to 64
years; 9 males and 5 females) were obtained in the early
recovery period. The creatinine clearance at biopsy was 6 to
124 mLlmin and the biopsies were made 2 to 30 days after onset
of ARF. The etiologies of ARF were: shock following surgical
operation, trauma, or postpartum hemorrhage; or sepsis. In 13
of the 24 patients poisoning or nephrotoxicity was considered to
have contributed to the ARF (paraquat, metronidazole, chlor-
protixene, diphenhydramine, truxal, methylene chloride, mor-
phine, and lithium), often accompanied by shock. Light micros-
copy showed the changes compatible with ischemic or
hypotensive ATN [14]. No cases of acute interstitial nephritis
were included in this material.
Definition of types of necrosis
(1.) Apoptosis. Apoptosis [19] appears as condensation and
increased electron density of the cell sap with densely packed
organelles. Vacuoles and cisterns are distended. Some mito-
chondria show cristal distension. The nucleus shows clumping
and margination of the chromatin. The nuclear membrane is
markedly folded and the nuclear volume appears decreased. In
the present material, this type of necrosis almost always af-
fected single cells, which contrasted strongly with the adjacent
normal epithelium.
(2.) Cellular disintegration (true necrosis). Disintegrated cells
usually have a very hydropic cell sap. The plasma membrane as
well as the membranes of nuclei and organelles are disrupted.
(3.) "Non-replacement" phenomenon. As suggested by
Solez et a! [14] at the light microscopic level, this change is
defined as the presence of defects in the epithelial covering of
the tubular basement membrane. By electron microscopy,
denuded basement membrane areas (probably the site of des-
quamated cells) are present focally and usually correspond to
no more than the size of one tubular cell. The denuded
basement membrane was always intact and basement mem-
brane breaks did not occur in any other parts of the tubular
profiles studied in the present investigation. The adjacent cells
were almost always normal. Rarely was a group of epithelial
cells seen in the process of desquamation.
Semiquantitative scoring
The proximal brush border appearing in each total tubular
cross section was evaluated and disappearance of microvilli
was scored from 0 to +3. A score of 0 was given for the "ideal
picture" as demonstrated in earlier studies of the normal
tubular structure in human biopsies [20—22]. When judging
tubular cells the effect of fixation and mechanical procedures
involved in biopsy taking and cutting for fixation must be taken
into consideration. Thus, the normal tubular structure observed
in perfusion fixed human tissue [23] cannot be used as a model.
For instance, it is normal in biopsy material to observe closed
or collapsed proximal lumina as well as the presence of large
cytoplasmie "blebs" originating from the luminal cell surface.
The scores + 1 and +2 were used for disappearance of
microvilli to a slight or moderate degree. The most severe
degree (+3) of brush border loss was used when only small
patches of brush border were identified in a total tubular cross
section, often just enough to identify it as a proximal tubule. A
proximal tubular cross section with total disappearance of
brush border cannot be identified as such, since the other
ultrastructural details distinguishing proximal from distal tu-
bules are of quantitative character and may be altered by the
disease. Therefore, by definition, the most severely altered
proximal tubules are excluded.
Reduction of basolateral infoldings was scored 0 to +3 on
each proximal and distal tubular cross section: 0 representing
the ideal normal state, +3 the total or almost total disappear-
ance of infoldings.
From the individual tubular scores, the mean score of each
biopsy was calculated. It was not considered feasible to score
each cell because the general quality of preservation varied with
the sample. In perfusion fixed material, cell membranes can be
measured quantitatively by morphometry [23]. For the reasons
mentioned earlier this was not considered possible in the
present immersion-fixed biopsy material, and the study was
therefore performed using a semiquantitative technique. The
scoring was performed without the observer's knowledge of the
clinical condition, and the biopsies from graft ARF were mixed
with others from patients suffering from rejection and cyclospo-
rime toxicity.
Morphometry of actin bundles
Bundles of actin fibrils present in the basal part of the tubular
cells were measured by a point-count technique described
earlier [17]. The volume of actin was related to the inner surface
area of the tubular basement membrane.
Statistics
The differences between the groups were investigated using
ANOVA followed by unpaired t-test. The level of significance
was set at 0.05. The reported values are mean SEM (standard
error of the mean).
Results
Light microscopic changes
There were no significant differences between the light mi-
croscopic changes in the ATN and ATN plus cyclosporine
toxicity groups. Therefore, for statistical analysis these two
groups were combined and compared with cases of pure cyclo-
sporine toxicity or normal function. The ATN group had
significantly greater tubular necrosis (P < 0.02; Table 2),
compared with both the cyclosporine and normal function
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Table 2. Light microscopic morphologic findings with ATN groups combined (0 to 3+ scale)
Semiquan-
titative
Creatinine
Interstial
inflamma-
tiOfla
interstitial
infiam-
mation
Tubular
necrosis Tubulitis Mitoses
Regener-
ation Edema
Tubular
dilatation
Vacuol-
ization Casts
ATN(l2) 676
134
1178
249
1.17
0.27
1.17
0.24
0.042
0.042
0.125
0.090
0.96
0.21
1.17
0.11
1.50
0.22
0.21
0.14
0.38
0.17
CsA (7) 310
52
1476
431
1.40
0.43
0.29
0.15
0.286
0.286
0.143
0.143
0.79
0.32
0.86
0.34
0.86
0.34
0.50
0.33
0.86
0.28
Normal (9) 138
8
425
32
1.00
0.2
0 0.28
0.121
0.056
0.056
0.39
0.14
0.75
0.15
0.20
0.11
0 0.28
0.14
ANOVA 0.0011 0.0315 NS 0.0003 NS NS NS NS 0.0005 NS NS
1-test
ATN vs. CsA 0.076 0.528 0.019 NS
ATN vs. Normal 0.001 0.014 0.0005 (0.053) (0.048) (0.037) 0.0001
CsA vs. Normal 0.001 0,015 0.045 0.102 (0.073)
Cells/mm2. Comparable figure from our previous study of biopsies from the steroid-azathioprine era were: graft ATN 943 137 (N = 13), graft
normal function 1271 123 (N = 5), native kidney controls 413 24 (N =20), native kidney ATN 683 83 (N 24), and recovery from ATN
985 119 (N = 7) (see Table 3 in Ref. 13).
Table 2A.
B.B.
loss
Tubular-
ization
Dilatation of
Bowman's
space
J.G.
apparatus
hyperplasia
Calcifi- Oxalate
cation deposition
Eosino-
philic
inclusions
Inter-
stitial
fibrosis
Hyaline
arteriolar
thickening
Pyknosis of
nuclei in
shed cells
ATN 0.79
0.27
0.36
0.17
0.136
0.136
0.22
0.12
0.71
0.24
0.79
1.30
0.17
0.11
0.46
0.16
0.54
0.25
0.46
0.14
CsA 0.14
0.14
0.20
0.21
0 0.21
0.21
0.43
0.30
0.79
0.36
0.071
0.071
0.14
0.14
1.00
0.31
0.80
0.12
Normal 0.11
0.11
0.28
0.28
0 0 0 0.06
0.06
0 0.33
0.19
0.11
0.11
0.94
0.05
ANOVA 0.05 NS NS NS 0.08 0.11 NS NS 0.06 0.02
ATN
vs. CsA NS NS NS NS NS
ATN
vs. normal 0.052 0.020 0.048 NS 0.0085
CsA
vs. normal NS NS 0.038 NS 0.018 NS
groups. The necrosis was far more overt than that encountered
in native kidney ATN and sometimes involved entire tubular
cross sections (Fig. 1). On average such lesions were present in
about 1/200 tubules (range 0 to 2.4%). This compares with an
incidence of <1/1500 tubules (0 to 0.8%) in biopsies from
azathioprine-treated patients with transplant ATN. Since a
single biopsy section may contain as few as 100 tubular profiles
it is clear that several sections may have to be examined to find
this circumferential necrosis lesion.
The ATN group also showed greater brush border loss and
parenchymal calcification, compared with the normal function
group. The pure cyclosporine group had significantly greater
hyaline arteriolar thickening (Fig. 2) than did biopsies from
normally functioning allografts. Four of the seven patients in
this group had implantation biopsies which showed that these
changes were not present in the donor kidney. Interestingly,
three other lesions thought to be characteristic of cyclosporine
nephrotoxicity were not significantly different between groups:
tubular vacuolization, eosinophilic cytoplasmic inclusions, and
juxtaglomerular apparatus hyperplasia. Calcium oxalate depo-
sition was significantly greater in the ATN and cyclosporine
toxicity groups than it was in controls. Patients with ATN had
significantly greater shedding of tubular cells with nonpyknotic
nuclei into the tubular lumen compared with other groups.
The most surprising finding was the nearly complete absence
of interstitial inflammation in the normal function control group.
Interstitial inflammation in this group when quantified by mor-
phology was almost exactly the same as that for native kidney
controls. In a previous study of transplant biopsies from the
steroid-azathioprine era the normal function group had three
times the number of interstitial inflammatory cells seen in native
kidney controls [13].
Despite the relative lack of interstitial inflammation, two of
the nine normal function biopsies showed significant venulitis
(Fig. 3), and one of them had an associated mild tubulitis as part
of the same lesion (Fig. 4). The remaining cases showed no or
very mild tubulitis (no more than 4 lymphocytes per tubular
cross section) [10]. Venulitis was also observed in three of the
seven cyclosporine toxicity cases. In one of the normal function
biopsies there was an aggregation of lymphocytes within the
lumen of an arcuate artery with adherence to the endothelium.
Careful serial sectioning revealed occasional lymphocytes be-
neath the endothelium (Fig. 5).
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Fig. I. Total necrotic tubular cross section in
a cyclosporine-treated patient with transplant
ATN. Note the sharp segmentation from
relatively normal to completely necrotic
tubular epithelium. The tubular cross section
at the top with a single pyknotic epithelial cell
nucleus and necrotic debris in the lumen is
probably from the same ncphron as the totally
necrotic cross section in the center of the
photograph. (Hematoxylin and eosin, x 625)
Fig. 2. Nodular P/iS-positive hyaline
thickening in the efferent arteriole of a
glomerulus in a patient with cyclosporine
nephrotoxicity. A biopsy obtained at the time
of implantation showed no significant
arteriolar alterations (PM, >< 270)
Electron micros c:opic changes
Ultrastruclure of cell surface membranes. The semiquantita-
tive scoring of the proximal brush border loss showed an
average score for grafts with stable function which was not
significantly different from that of native controls (Table 3). The
score for pure ATN was significantly higher than that for stable
function (P < 0.05). The groups with pure cyclosporine toxicity
and with cyclosporine toxicity and ATtN had higher average
scores than the group with stable function, but the differences
were not significant. The scores for reduction of basolateral
surfaces were also generally higher in all groups with ATN
and/or cyclosporine toxicity compared with stable function, but
these differences were also not significant.
Tubular cell necruses. Various types occurred with the
frequencies shown in Table 4. The numbers fluctuated greatly
between biopsies, and in spite of average values of up to more
than 10%, no significant differences were present. Some com-
plete tubular cross sections showed severe degenerative
changes with coarse cytoplasmic vacuoles and disruption of
external cell membranes. Although the nuclei of these cells
were preserved without signs of pyknosis or karyorrhexis,
these tubular cross sections were considered to be necrotic.
¼
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Fig. 3. Venulitis in an allograft biopsy from a
patient with normal function and no
subsequent signs of rejection. (Hematoxylin
and eosin, x 270)
The phenomenon was always strictly focal: that is, damaged
tubules were situated adjacent to others which were well
preserved. Necrotic tubules were present in biopsies with
stable function (2 out of 94 proximal tubules) as welt as in all the
other groups (ATN: 3/52 proximal tubules; cyelosporine toxic-
ity 5/44 proximal tubules; ATN + CsA-tox: 2/48 proximal
tubules and 3/14 distal tubules). There was, thus, a tendency
toward more frequent occurrence of totally necrotic cross
sections by electron microscopy in the groups with ATN and/or
cyclosporine toxicity, but the difference was not significant.
General ultrastructural changes of the tubules. Changes
previously noted to be associated with cyclosporine toxicity
were rare. Giant mitochondria were only seen in two proximal
cells, one in a biopsy from the stable function group, the other
in the cyclosporine toxicity group. Isometric vacuoles were
present to a variable but only moderate degree in all cyclospo-
rine treated groups. Phagolysosomes containing fiocculent mat-
ter, pieces of myelin-like figures or electron dense inclusions
were frequent in the proximal tubules in ATN and/or cyclospo-
rine toxicity. They also occurred in biopsies from patients with
stable function, but not more often than in native controls. A
special type of lysosome with multiple electron dense granules
was frequent in all groups, including stable function, as they
were in azathioprine treated patients with ATN. They were
very rare in native controls and native ATN. They seem to be
present in the transplanted kidney without any relation to
transplant ATN or treatment with azathioprine or cyclosporine.
Abnormal lysosomes were not present in distal tubules. Proxi-
mal tubules were moderately dilated in patients with ATN
compared with stable function. Casts occurred in all groups,
including those with stable function. They consisted of appar-
ently viable cells and of cellular debris. Pigmented casts (fre-
quent in native ATN) were rare. A few tubular lumina con-
tamed crystals, which could also occur between tubular
epithelial cells.
Actinfibril bundles. The mean volumes of actin fibril bundles
in biopsies from patients with stable function were not signifi-
cantly different from those of native controls, and those from
patients with ATN and/or cyclosporine toxicity were in the
same range (Table 5). This is in contrast to the findings in native
ATN, in which the actin fibril bundles are strongly hypertro-
phied and in transplant ATN in azathioprine treated patients
where the volume is markedly diminished [14]. Diverticular
outpouchings of the tubular basement membrane with thick
bundles of actin attached to the edges of the diverticular were
very rare in the present material.
Discussion
Our previous studies of biopsies from renal transplant pa-
tients immunosuppressed with steroids and azathioprine
yielded two major unanticipated findings: (1) that there are
remarkable morphologic differences between the morphology
of ATN in transplanted and native kidneys [13, 14] and (2) that
stable, well-functioning renal allografts may have a substantial
interstitial infiltrate of mononuclear inflammatory cells unre-
lated to clinical rejection [13, 15]. The present study of biopsies
from renal allograft recipients immunosuppressed with cyclo-
sporine and steroids has yielded even more surprising observa-
tions. With cyclosporine therapy the interstitial infiltrate in the
well-functioning graft is no longer observed, but an impressive
venulitis is sometimes seen. An interstitial infiltrate appears in
the presence of ATN or cyclosporine nephrotoxicity. A very
mild tubulitis sometimes accompanies this infiltrate, exceeding
the four lymphocyte/most affected tubular cross section limit
used in the l3anff Schema [9, 10] only in tubules which are in
direct continuity with venulitis lesions.
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Fig. 4. Venulitis lesion in another normal
function biopsy. A. Low power photograph
showing relatively uninflamed surrounding
interstitium. B. Higher power picture showing
tubulitis lesion with five invading lymphocytes
in direct continuity with the venulitis process.
(Hematoxylin and eosin, A x 270, B x 435)
Our observations of a paucity of inflammatory infiltrate in the
interstitium of transplants with normal function on low dose
cyclosporine therapy extends the findings of McWhinnie et al
[24] from the era when higher doses were used showing
significantly reduced (but still considerable) interstitial inflam-
mation in stable function grafts on cyclosporine immuno sup-
pression compared with azathioprine. Porter has previously
drawn attention to the inflammatory infiltrates seen in isografts
[25]. Presumably this infiltrate is due in part to ischemia and
consequent tubular damage. The infiltrate in ATN and cyclo-
sporine toxicity in the present study may be explainable on an
isehemic (vasoconstrictive) basis.
The venulitis lesion observed in two normal function patients
in the present study has not been previously reported in stable
kidney grafts. The possibility exists that this lesion is specill-
cally related to cyclosporine therapy. Mennander et al 1261 have
recently reported a specific "endothelialitis" which occurs in
rat aortic allografts under cyclosporine therapy but not when
azathioprine or steroids are used.
In this study the only lesion which distinguished cyclosporine
nephrotoxieity from other groups was hyaline thickening of
arterioles. Features emphasized by other authors such as iso-
metric vacuolization, eosinophilic cytoplasmic inclusions, and
microcalcification 13, 4] were not prominent on the present
study, perhaps because of the relatively low doses of cyclospo-
rine used in the period 1986 to 1990 in our institutions compared
with earlier practice. Alexopoulos et al 127] have also recently
reported a study in which arteriolar lesions represented the only
distinguishing characteristic of acute cyclosporine nephrotox-
icity.
Soles ci ol: Morphology of transplant AIls' 1065
Fig. 5. Inflammatory lesion in arcuate artery
at corticomeduliary junction in a patient with
normal function. This lesion was extremely
focal and in most sections had the character
of a loose intraluniinai aggregate of
lymphocytes. However, at the level depicted
in this picture it can be seen that a few of the
lymphocytes appear to be underneath the
endothelium. (Hematoxylin and eosin, x 270)
Proximal Proximal Distalbrush -_--_
border Basolat. inf.
The type of tubular injury seen in ATN eases in the present
study deserves discussion. For many years the authors have
been using the term "acute tubular necrosis" in quotation
marks because overt tubular necrosis was not commonly ob-
served in the condition referred to as ATN [13, 14, 281. Our
observations in the present study have caused us to remove the
quotation marks for transplant ATN in cyclosporine-treated
patients since true necrosis of entire tubular cross sections is a
feature of this special category of ATN. Such lesions are very
focal, however, and may require examination of several sec-
tions to identify. The focality of this lesion means that it is more
accurately assessed by light microscopy than by electron mi-
croscopy because of sampling error considerations. Little tu-
bular necrosis was observed in the cyclosporine toxicity group
(and the necrosis that was observed may have been due to an
unrecognized minor component of ATN). However, cyclospo-
rine therapy clearly enhanced the tubular necrosis observed in
the ATN group.
The other tubular injury phenomenon we have emphasized
recently, urinary shedding of viable tubular cells in ATN,
occurs to a pronounced degree in transplant ATN in cyclospo-
rine-treated patients [16]. The observation of large numbers of
shed tubular cells, with nonpylsnotic nuclei in tubular lumina in
the present study (Table 2) is consistent with this observation.
Table 3. Electron microscopic cell surface changes (0 to 3 + scale)
12 0.04 0.09
11 1.24 0.88
9 0.33 0.35
0.17 0.30
1.65 0.44
0.21 0.40
0.14 0.23
2.01 0.64
0.03 0.05
Table 4. Electron microscopic tubular cell necrosis and
nonreplacement (% of cells affected)
Non- Cell necroses
N replacement (54) disrupt. Apopt.
Native controls
Native ATN
Graft ATN, Aza therapy
Four CsA therapy
groups;
Graft, stable fx.
Graft, ATN
Graft, pure CsA tox.
Graft, ATN + CsA
tax.
CsA series statistics
Graft ATN vs. stable
function
Graft CsA toxicity vs.
stable function
Graft ATN + CsA tox
vs. stable function
9 0.16 0.06
7 0.57 0.21
7 0.41 0.28
5 0.22±0.13
0.09 0.06
0.44 0.31
0.32 0.16
0.14 0.09
12
11
9
0.05 0.02
0.25 0.19
0.06 0.14
0.10 0.10
0
0.80
0.71
Proximal convoluted tubules
Native controls
Native ATN
Graft ATN, Aza therapy
Four CsA therapy groups:
Graft stable fx.
Graft ATN
Graft pure CsA tox.
Graft ATN + CsA tox.
Distal convoluted tubules
Native controls
P < 0.05 NS NS Native ATN
Graft ATN, Aza
Four CsA therapy groups:NS NS NS
Graft stable fx.
NS NS NS Graft ATN
Graft pure CsA lox.
Graft ATN + CsA tox.
Data in first three groups are from previous publications 13, 18].
9 0
7 0
7 0.34
5 0
12 0.70
9 0.47
6 0.34
6 2.06
7 0.33
4 0
0 0
0 1.60
1.28 1.28
0 4.70
1.70 8.03
0.64 8.81
0.02 0.11
0 2.70
0 1.20
0.47 6.05?
0 10.90
0 10.29
1.66 5.63
0 3.36
Data in first three groups are from previous publications [13, 181.
Owing to the large amount of scatter in the data there are no significant
differences among the CsA groups.
af < 0.05 versus controls
b P < 0.001 versus controls
t a.-- - e
t 'I
p. •.
I4'
.4 —'
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Table 5. Volume of actin fibril bundles related to area of tubular basement membrane
Proximal tubules Distal tubules
N Mean SEM N Mean SEM
1) Native controlsa 9 176 18 8 127 9
) Native ATN 8 441 35 8 510 32
3) Tx Aza ATNb 9 23 3.1 9 17 2.6) CsA series: Stable fx 9 157 30 9 90 18
5) CsA series: Pure ATN 7 122 52 5 52 18
S) CsA series: Pure CsA tox 7 196 64 7 74 13
7) CsA series: ATN ÷ CsA mx 5 146 55 4 93 62) CsA series: 5 + 6 + 7 19 165 35 19 70 13
Despite the highly significant differences observed in the first three groups from previous publications [13, 17], no differences were observed
smong the CsA series groups.
a Data from Olsen et al, Ultrastruct Pathol 7:241—259, 1984
b Data from Olsen et al, Medicine 68:173—187, 1989
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